Cognetivity
Platform technology for early detection of dementia.
Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's disease.
Our patented rapid cognitive analysis technology aims to make early detection a reality, and aims to bring the benefits of being: easier to administer, more accessible, less expensive, allowing earlier and more accurate diagnosis.
Visit website: https://www.cognetivity.com/
Cognetivity is also referenced in the following:
Hacking your health
BBC Click meets biohackers and companies who believe it will be possible to live on to well beyond 100
People at Cognetivity
Cognetivity News
OptiMind app designed for early diagnosis of dementia with simple tapping
Wired - 11-Nov-2021
A 5-minute test can assess the early risk of getting dementia
Read more...